Download PDF
Dtsch Med Wochenschr 2010; 135(37): 1803-1814
DOI: 10.1055/s-0030-1263323
CME | Review article
Angiologie, Kardiologie, Pneumologie
© Georg Thieme Verlag KG Stuttgart · New York

Die akute Lungenembolie

Acute pulmonary embolismS. Braun1 , J. Beyer-Westendorf2 , I. Platzek3 , G. Höffken1 , M. Halank1
  • 1Medizinische Klinik I – Pneumologie, Universitätsklinikum Carl-Gustav-Carus, Dresden
  • 2Medizinische Klinik III – Angiologie, Universitätsklinikum Carl-Gustav-Carus, Dresden
  • 3Klinik für Radiologie, Universitätsklinikum Carl-Gustav-Carus, Dresden
Further Information

Publication History

eingereicht: 8.4.2010

akzeptiert: 26.8.2010

Publication Date:
07 September 2010 (online)

Also available at
   Permissions and Reprints
Preview

Corrected by:

Die akute LungenembolieDtsch Med Wochenschr 2010; 135(44): 2208-2208
DOI: 10.1055/s-0030-1267503

Zusammenfassung

Der Verlauf einer akuten Lungenarterienembolie (LAE) ist gekennzeichnet durch ein breites klinisches Spektrum vom asymptomatischen Verlauf bis zum plötzlichen Herztod, mit einer durchschnittlichen Mortalität von 11 % innerhalb von 2 Wochen. Aufgrund der potentiellen vitalen Bedrohung muss jeder klinische Verdacht auf eine Lungenembolie definitiv abgeklärt werden. Das Mortalitätsrisiko von Patienten mit LAE lässt sich auf Basis ihrer hämodynamischen Instabilität abschätzen. Unterschieden wird eine Hoch-Risiko-Gruppe (30-Tage Mortalität > 15 %) und eine Nicht-Hochrisiko-Gruppe (30-Tage Mortalität < 15 %). Empfohlen wird ein Risiko-adaptiertes Patientenmanagement, wobei sich der diagnostische und der therapeutische Algorithmus zwischen den beiden Gruppen erheblich unterscheidet. Patienten mit Verdacht auf Hochrisiko-LAE sind ein medizinischer Notfall, mit der Notwendigkeit einer umgehenden Diagnostik mittels Multidetector-CT-Pulmonalisangiographie (MD-CTPA) oder Echokardiographie sowie ggf. prompter Durchführung einer rekanalisierenden Therapie (Thrombolyse/Embolektomie). Für das Managment von Patienten der Nicht-Hochrisiko-Gruppe hat sich eine schrittweise Diagnostik mit dokumentierter Anwendung eines Wahrscheinlichkeits-Scores etabliert. Die ungezielte Bestimmung von D-Dimeren sollte vermieden werden. Bei Nicht-Hochrisiko-LAE ist die umgehende therapeutische Antikoagulation Therapie der Wahl.

Abstract

Acute pulmonary embolism (APE) presents with a broad clinical spectrum ranging from an even asymptomatic course to sudden cardiac death. Because APE is potentially life-threatening every suspicion of APE has to be clarified promptly by validated diagnostic algorithms. On the basis of the patients haemodynamic instability high-risk APE and non-high-risk APE is differentiated. Based on the presence of shock or hypotension every patient with suspicion of APE should promptly be stratified as high-risk APE or non-high-risk APE. There is a considerable difference in the diagnostic and therapeutic algorithms between high-risk and non-high-risk APE. In suspicion of high-risk APE the patients require immediate diagnosis by multidetector CT or echocardiography and immediate recanalization of the occluded pulmonary arteries by thrombolysis or embolectomy. In haemodynamically stable patients sequential diagnostic workup and prompt therapeutic anticoagulation is recommended.

Schlüsselwörter

Lungenembolie - LAE - venöse Thrombembolie - Thrombolyse

Keywords

pulmonary embolism - APE - venous thrombembolism - thrombolysis

Literatur

  • 1 Agnelli G, Becattini C. Acute pulmonary embolism.  N Engl J Med. 2010;  363 266-274
    Search in Google Scholar
  • 2 Agnelli G, Prandoni P, Becattini C. et al . Extended oral anticoagulant therapy after a first episode of pulmonary embolism.  Ann Intern Med. 2003;  139 19-25
    Search in Google Scholar
  • 3 Anderson D, Barnes D. The use of leg venous ultrasonography for the diagnosis of pulmonary embolism.  Semin Nucl Med. 2008;  38 412-417
    Search in Google Scholar
  • 4 Anderson F A, Spencer F A. Risk factors for venous thrombembolism.  Circulation. 2003;  107 I-9-I-16
    Search in Google Scholar
  • 5 AWMF online: Leitlinien-Register Nr 065/002: Diagnostik und Therapie der Venenthrombose und der Lungenembolie. Überarbeitete Version von 06/2010. 
  • 6 Barritt D W, Jordan S C. Anticoagulant drugs in the treatment of pulmonary embolism.  A controlled trial Lancet. 1960;  275 1309-1312
    Search in Google Scholar
  • 7 Becattini C, Agnelli G. Predictors of mortality from pulmonary embolism and their influence on clinical management.  Thromb Haemost. 2008;  100 747-751
    Search in Google Scholar
  • 8 Becattini C, Vedovati M C, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis.  Circulation. 2007;  116 427-433
    Search in Google Scholar
  • 9 Beyer J, Schellong S. The search for deep vein thrombosis, in Konstantinides S „Management of Acute Pulmonary Embolism”. Humana Press; 2007: 43-55
    Search in Google Scholar
  • 10 Bourjeily G, Paidas M, Khalil H, Montella K R, Rodger M. Pulmonary embolism in pregnancy.  Lancet. 2010;  375 500-512
    Search in Google Scholar
  • 11 Capstick T, Henry M T. Efficacy of thrombolytic agents in the treatment of pulmonary embolism.  Eur Respir J. 2005;  26 864-674
    Search in Google Scholar
  • 12 Chan W S, Chunilal S, Lee A, Crowther M, Rodger M, Ginsberg J S. A red blood cell agglutination D-Dimer test to exclude deep venous thrombosis in pregnancy.  Ann Intern Med. 2007;  147 165-170
    Search in Google Scholar
  • 13 Cohn D, Vansenne F, de Borgie C, Middeldorp S. Thrombophilia testing for prevention of recurrent venous thrombembolism. Cochrane database syst Reviews; 2009 CD007069.
    Search in Google Scholar
  • 14 Crushman M. Epidemiology and risk factors for venous thrombosis.  Semin Hematol. 2007;  44 62-69
    Search in Google Scholar
  • 15 Dalen J E. Should patients with venous thrombembolism be screened for thrombophilia?.  Am J Med. 2008;  121 458-463
    Search in Google Scholar
  • 16 Dellas C, Puls M, Lankeit M. et al . Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism.  J Am Coll Cardiol. 2010;  55 2150-2157
    Search in Google Scholar
  • 17 Dong B R, Hao Q, Yue J, Wu T, Liu G J. Thrombolytic therapy for pulmonary embolism The Cochrane Collaboration. The Cochrane Library; 2009 2 CD004437.
    Search in Google Scholar
  • 18 Farmer-Boatwright M, Roubey R. Venous thrombosis in the antiphospholipid syndrome.  Arterioscler Thromb Vasc Biol. 2009;  29 321-325
    Search in Google Scholar
  • 19 Fengler B T, Bardy W J. Fibrinolytic therapy in pulmonary embolism: an evidenced based treatment algorithm.  Am J Emerg Med. 2009;  27 84-95
    Search in Google Scholar
  • 20 Giannitis E, Müller-Bardorff M, Kurowski V. et al . Independent prognostic value of cardiac Troponin T in patients with confirmed pulmonary embolism.  Circulation. 2000;  102 211-217
    Search in Google Scholar
  • 21 Ginsberg J, Wells P S, Kearon C. et al . Sensitivity and specificity of a rapid whole blood assay for d-dimer in the diagnosis of pulmonary embolism.  Ann Intern Med. 1988;  129 1006-1011
    Search in Google Scholar
  • 22 Goldhaber S, Haire W, Feldstein M. et al . Alteplase versus heparin in acute pulmonary embolism: randomised trail assessing right-ventricular function and pulmonary perfusion.  Lancet. 1993;  341 507-511
    Search in Google Scholar
  • 23 Goldhaber S Z, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).  Lancet. 1999;  353 1386-1389
    Search in Google Scholar
  • 24 Heit J A, Kobbervig C, James A H, Petterson T M, Bailey K, Melton L J. Trends in the incidence of venous thrombembolism during pregnancy or postpartum: A 30-year popultion-based study.  Ann Intern Med. 2005;  143 697-706
    Search in Google Scholar
  • 25 Heit J A, Mohr D, Silverstein M D, Petterson T, O’Fallon M, Melton J L. Predictors of recurrence after deep vein thrombosis and pulmonary embolism.  Arch Intern Med. 2000;  160 761-768
    Search in Google Scholar
  • 26 Heit J A, Silverstein M, Mohr D. et al . Predictors of survival after deep vein thrombosis and pulmonary embolism.  Arch Intern Med. 1999;  159 445-453
    Search in Google Scholar
  • 27 Heit J A. The Epidemiology of venous thrombembolism in the communitiy: implications for prevention and management.  J Thromb Thrombolysis. 2006;  21 23-29
    Search in Google Scholar
  • 28 Hull R, Raskob G, Brant R, Pineo G, Valentine. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy: the emerging theme of delayed recurrence.  Arch Intern Med. 1997;  157 2317-2321
    Search in Google Scholar
  • 29 Husted S. Treatment of pulmonary embolism at home?.  Thrombosis Research. 2010;  126 3-4
    Search in Google Scholar
  • 30 Janjua M, Badsah A, Matta F. et al . Treatment of acute pulmonary embolism as outpatients of following early discharge.  Thromb Haemost. 2008;  100 756-761
    Search in Google Scholar
  • 31 Jeres-Sanchez C, Ramirez-Rivera A, de Lourdes G M. et al . Streptokinase and heparin versus heparin alone in massive pulmonary embolism; a randomized controlled trail.  J Thromb Thrombolysis. 1995;  2 227-229
    Search in Google Scholar
  • 32 Kasper W, Konstantinides S, Geibel A. et al . Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry.  J Am Coll Cardiol. 1997;  30 1165-1171
    Search in Google Scholar
  • 33 Kearon C, Kahn S, Agnelli G. et al . Antithrombotic therapy for venous thrombembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest. 2008;  133 454-545
    Search in Google Scholar
  • 34 Klok F A, Mos I C, Huisman M V. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and metaanalysis.  Am J Repir Crit Care Med. 2008;  178 425-430
    Search in Google Scholar
  • 35 Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.  N Engl J Med. 2002;  347 1143-1150
    Search in Google Scholar
  • 36 Konstantinides S, Geibel A, Olschewski M. et al . Importance of cardiac Troponin I and T in risk stratification of patients with acute pulmonary embolism.  Circulation. 2002;  106 1263-1268
    Search in Google Scholar
  • 37 Konstantinides S, Janssens U, Mayer E, Hasenfuß G. Kommentar zu den ESC-Leitlinien„Guidelines on Diagnosis and Management of Acute Pulmonary Embolism”.  Kardiologe. 2009;  3 272-282
    Search in Google Scholar
  • 38 Konstantinides S. Acute pulmonary embolism.  N Engl J Med. 2008;  359 2804-2813
    Search in Google Scholar
  • 39 Kucher N, Rossi E, DeRosa M, Goldhaber S Z. Massive pulmonary embolism.  Circulation. 2006;  113 577-582
    Search in Google Scholar
  • 40 Kürkiciyan I, Meron G, Sterz F. et al . Pulmonary embolism as cause of cardiac arrest.  Arch Intern Med. 2000;  160 1529-1535
    Search in Google Scholar
  • 41 Lankeit M, Friesen D, Aschoff J. et al . Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism.  Eur Heart J. 2010;  31 1836-1844
    Search in Google Scholar
  • 42 Lankeit M, Konstantinides S. Thrombolysis for pulmonary embolism: past, present and future.  Thromb Haemost. 2010;  103 877-883
    Search in Google Scholar
  • 43 Lankeit M. Thrombolysis for hemodynamically stable patients with pulmonary embolism: still searching for the intermediate-risk group.  Thrombosis Research. 2009;  124 647-648
    Search in Google Scholar
  • 44 Le Gal G, Righini M, Roy P M. et al . Prediction of pulmonary embolism in the emergency department: the revised Geneva score.  Ann Intern Med. 2006;  144 165-171
    Search in Google Scholar
  • 45 Lee A Y, Rickles F R, Julian J A, Gent M, Baker R I, Bowden C. Randomized comparison of low molecular weight heparin and coumarin derivates on the survival of patients with cancer and venous thrombembolism.  J Clin Oncol. 2005;  23 2123-2129
    Search in Google Scholar
  • 46 Levine M, Gent M, Hirsh J. et al . A comparison of low-moleular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis.  N Eng J Med. 1996;  334 677-681
    Search in Google Scholar
  • 47 Lifjering W M, Brouwer J L, Veeger N J. et al . Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.  Blood. 2009;  113 5314-5322
    Search in Google Scholar
  • 48 Lyman G, Khorana A, Falanga A. et al . American Society of Clinical Oncology Guideline: Recommendations for venous thrombembolism prophylaxis and treatment in patients with cancer.  J Clin Oncol. 2007;  25 5490-5505
    Search in Google Scholar
  • 49 Marik P E, Plante L A. Venous thrombembolic disease and pregnancy.  N Engl J Med. 2008;  359 2025-2033
    Search in Google Scholar
  • 50 Otero R, Trujillo-Santos J, Cayuela A. et al . The Registro Informatizado de la Enfermedad Thromboembolica (RIETE) Investigators: Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index?.  Eur Respir J. 2007;  30 1111-1116
    Search in Google Scholar
  • 51 Otero R, Uresandi F, Jimenez D. et al . Home treatment in pulmonary embolism.  Thrombosis Research. 2010;  126 e1-e5
    Search in Google Scholar
  • 52 Perrier A. D-dimer for suspected pulmonary embolism.  Chest. 2004;  125 807-809
    Search in Google Scholar
  • 53 Stein P, Fowler S, Lawrence. PIOPED II Investigators . Multidetector Computed Tomography for Acute Pulmonary Embolism.  N Engl J Med. 2006;  354 2317-2327
    Search in Google Scholar
  • 54 PIOPED Investigators . Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators.  JAMA. 1990;  263 2753-2759
    Search in Google Scholar
  • 55 Proudfoot A, Melley D, Shah P. Role of thrombolysis in haemodynamically stable patients with pulmonary embolism.  Thorax. 2008;  63 853-854
    Search in Google Scholar
  • 56 Puls M, Dellas C, Lankeit M. et al . Heart-type fatty acid-binding proteins permits early risk stratification of pulmonary embolism.  Eur Heart J. 2007;  28 224-229
    Search in Google Scholar
  • 57 Righini M, Aujesky D, Roy P M. et al . Clinical usefulness of D-Dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism.  Ach Intern Med. 2004;  164 2483-2487
    Search in Google Scholar
  • 58 Righini M, Le G al F, Aujesky D. et al . Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trail.  Lancet. 2008;  371 1343-1352
    Search in Google Scholar
  • 59 Rose P S, Punjabi N M, Pearse D B. Treatment of right heart thrombemboli.  Chest. 2002;  121 806-14
    Search in Google Scholar
  • 60 Roy P M, Meyer G, Vielle B. et al . Appropiateness of diagnostic management and outcomes of suspected pulmonary embolism.  Ann Intern Med. 2006;  144 157-164
    Search in Google Scholar
  • 61 Sanchez O, Trinquart L, Colombet I. et al . Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review.  Eur Heart J. 2008;  29 1569-1577
    Search in Google Scholar
  • 62 Sandler D A, Martin J F. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?.  J R Soc Med. 1989;  82 203-205
    Search in Google Scholar
  • 63 Silverstein M D, Heit J A, Mohr D N, Petterson D M, O’Fallon W M, Melton L J. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.  Arch Intern Med. 1998;  158 585-593
    Search in Google Scholar
  • 64 Simpson E L, Stevenson M D, Rawdin A, Papaioannou. Thrombophilia testing in people with venous thrombembolism: Systematic review and cost-effectiveness analysis.  Health technol Assess. 2009;  13 1-91
    Search in Google Scholar
  • 65 Smith S B, Geske J, Maguire J, Zane N, Carter R, Morgenthaler T. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism.  Chest. 2010;  137 1382-1390
    Search in Google Scholar
  • 66 Squizzato A, Galli M, Dentalli F, Ageno W. Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review.  Eur Respir J. 2009;  33 1148-1155
    Search in Google Scholar
  • 67 Stein P, Chenevert T, Fowler S. et al . Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism. (PIOPED III).  Ann Intern Med. 2010;  152 434-443
    Search in Google Scholar
  • 68 Stein P, Henry J. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes.  CHEST. 1997;  112 974-979
    Search in Google Scholar
  • 69 Stein P, Henry J W. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy.  Chest. 1995;  108 978-981
    Search in Google Scholar
  • 70 Stein P, Hull R, Matta F, Yaekoub A. Early discharge of patients with venous thrombembolism: Implications Regarding Therapy.  Clin Appl Thromb hemost. 2010;  16 141-145
    Search in Google Scholar
  • 71 Tapson V F. Acute Pulmonary Embolism.  N Engl J Med. 2008;  358 1037-1052
    Search in Google Scholar
  • 72 Tardy B, Venet C, Zeni F. et al . Short term effect of recombinant plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: Results of a meta-analysis involving 464 patients.  Thromb Res. 2009;  124 672-677
    Search in Google Scholar
  • 73 Torbicki A, Perrier A, Konstantinides S. TASK FORCE for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) . Guidelines on the diagnosis and management of acute pulmonary embolism.  Eur Heart J. 2008;  29 2276-2315
    Search in Google Scholar
  • 74 Ten Wolde M, Söhne M, Quak E. et al . Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism.  Arch Intern Med. 2004;  164 1685-1689
    Search in Google Scholar
  • 75 To M S, Hunt B J, Nelson-Piercy C. A negative D-dimer does not exclude venous thrombembolism (VTE) in pregnancy.  J Obstet Gynaecol. 2008;  28 222-240
    Search in Google Scholar
  • 76 Verstraete M, Miller G A, Bounameaux H. et al . Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.  Circulation. 1988;  77 353-360
    Search in Google Scholar
  • 77 Vuilleumier N, Le G al G, Verschuren F. et al . Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multi-center propective study.  J Thrombosis and Haemostasis. 2008;  7 391-398
    Search in Google Scholar
  • 78 Wan S, Quinlan D, Agnelli G, Eikelboom J. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism.  Circulation. 2004;  110 744-749
    Search in Google Scholar
  • 79 Wells P S, Anderson D, Rodger M. et al . Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED-D-dimer.  Thromb Haemost. 2000;  83 416-420
    Search in Google Scholar
  • 80 Zheng Z J, Croft J, Giles W, Mensah G. Sudden cardiac death in the United States, 1989 to 1998.  Circulation. 2001;  104 2158-2163
    Search in Google Scholar
  • 81 Zhu T, Martinez I, Emmerich J. Venous thrombembolism. Risk factors for recurrence.  Arteriocler Thromb Vasc Biol. 2009;  29 298-310
    Search in Google Scholar

Dr. med. Silke Braun

Medizinische Klinik I – Pneumologie
Universitätsklinikum Carl-Gustav-Carus Dresden

Fetscherstr. 74

01307 Dresden

Email: Silke.Braun@uniklinikum-dresden.de